Tony Weir appointed as new Chief Financial OfficerReleased: 28 October 2008Interim results for six months ended 31 July 2008
Released: 28 October 2008
Zebrafish platform research agreement signed with Johnson & Johnson PTE LimitedReleased: 13 October 2008
Co-development agreement signed with the Lilly TB Drug Discovery InitiativeReleased: 7 October 2008
Co-development agreement signed with Orient Pharma in Sialorrhoea programmeReleased: 24 September 2008Directorate change
Released: 22 August 2008
Worldwide licensing agreement signed with BioMarin for Duchenne muscular dystrophy programmeReleased: 22 July 2008Summit report progress in DMD programme at International conferenceReleased: 29 April 2008Positive results from Phase I clinical trial of SMT D002 for the treatment of acneReleased: 15 April 2008Summit Presents the Benefits Zebrafish Bring to Drug Discovery at International ConferencesReleased: 9 April 2008 £500,000 Contract Wins by Dextra Carbohydrate Service BusinessReleased: 21 February 2008Pre-close Trading StatementReleased: 31 January 200SMT D002 Enters Phase II Clinical Trials for the treatment of sialorrhoea, a symptom of Parkinson's diseaseReleased: 16 January 2008
